Vanguard Capital Management’s Alto Neuroscience ANRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$43.2M Buy
1,690,753
+301,276
+22% +$9.05M ﹤0.01% 1967
2026
Q2
$36.7M Buy
1,389,477
+182,452
+15% +$4.22M ﹤0.01% 2112
2026
Q1
$27.1M Buy
+1,207,025
New +$22.4M ﹤0.01% 2181

Other funds holding ANRO

Vanguard Capital Management's ANRO Position: Q3 2026 in Review

Vanguard Capital Management increased its Alto Neuroscience (ANRO) stake by 22% in Q3 2026, buying an estimated $9.05M and bringing the position to 1,690,753 shares worth $43.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1967.

Vanguard Capital Management first reported a position in ANRO in Q1 2026 and has held it in 3 quarters since. 133 funds tracked by Wall St. Rank hold ANRO as of Q3 2026.

  • Vanguard Capital Management held 1,690,753 shares of Alto Neuroscience worth $43.2M as of Q3 2026.
  • Vanguard Capital Management bought 301,276 Alto Neuroscience shares in Q3 2026, an estimated $9.05M.
  • Alto Neuroscience made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1967 holding.
  • Vanguard Capital Management first reported a position in Alto Neuroscience in Q1 2026 and has held it in 3 quarters since.
  • 133 funds tracked by Wall St. Rank held Alto Neuroscience as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.